Literature DB >> 19508243

A Bayesian semiparametric survival model with longitudinal markers.

Song Zhang1, Peter Müller, Kim-Anh Do.   

Abstract

We consider inference for data from a clinical trial of treatments for metastatic prostate cancer. Patients joined the trial with diverse prior treatment histories. The resulting heterogeneous patient population gives rise to challenging statistical inference problems when trying to predict time to progression on different treatment arms. Inference is further complicated by the need to include a longitudinal marker as a covariate. To address these challenges, we develop a semiparametric model for joint inference of longitudinal data and an event time. The proposed approach includes the possibility of cure for some patients. The event time distribution is based on a nonparametric Pólya tree prior. For the longitudinal data we assume a mixed effects model. Incorporating a regression on covariates in a nonparametric event time model in general, and for a Pólya tree model in particular, is a challenging problem. We exploit the fact that the covariate itself is a random variable. We achieve an implementation of the desired regression by factoring the joint model for the event time and the longitudinal outcome into a marginal model for the event time and a regression of the longitudinal outcomes on the event time, i.e., we implicitly model the desired regression by modeling the reverse conditional distribution.

Entities:  

Mesh:

Year:  2009        PMID: 19508243      PMCID: PMC3045702          DOI: 10.1111/j.1541-0420.2009.01276.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  A Bayesian semiparametric accelerated failure time model.

Authors:  S Walker; B K Mallick
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Bayesian approaches to joint cure-rate and longitudinal models with applications to cancer vaccine trials.

Authors:  Elizabeth R Brown; Joseph G Ibrahim
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

3.  The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure.

Authors:  Ngayee J Law; Jeremy M G Taylor; Howard Sandler
Journal:  Biostatistics       Date:  2002-12       Impact factor: 5.899

4.  Evaluating surrogate markers of clinical outcome when measured with error.

Authors:  U G Dafni; A A Tsiatis
Journal:  Biometrics       Date:  1998-12       Impact factor: 2.571

5.  Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.

Authors:  Donna K Pauler; Dianne M Finkelstein
Journal:  Stat Med       Date:  2002-12-30       Impact factor: 2.373

6.  Models for empirical Bayes estimators of longitudinal CD4 counts.

Authors:  M P LaValley; V DeGruttola
Journal:  Stat Med       Date:  1996 Nov 15-30       Impact factor: 2.373

7.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

8.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

9.  Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Authors:  H Ballentine Carter; Luigi Ferrucci; Anna Kettermann; Patricia Landis; E James Wright; Jonathan I Epstein; Bruce J Trock; E Jeffrey Metter
Journal:  J Natl Cancer Inst       Date:  2006-11-01       Impact factor: 13.506

10.  Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer.

Authors:  J A Ellerhorst; S M Tu; R J Amato; L Finn; R E Millikan; L C Pagliaro; A Jackson; C J Logothetis
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

View more
  8 in total

1.  A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time.

Authors:  Sheng Luo
Journal:  Stat Med       Date:  2013-09-06       Impact factor: 2.373

Review 2.  Joint latent class models for longitudinal and time-to-event data: a review.

Authors:  Cécile Proust-Lima; Mbéry Séne; Jeremy M G Taylor; Hélène Jacqmin-Gadda
Journal:  Stat Methods Med Res       Date:  2012-04-19       Impact factor: 3.021

3.  Bayesian inference for longitudinal data with non-parametric treatment effects.

Authors:  Peter Müller; Fernando A Quintana; Gary L Rosner; Michael L Maitland
Journal:  Biostatistics       Date:  2013-11-26       Impact factor: 5.899

4.  Rubbery Polya Tree.

Authors:  Luis E Nieto-Barajas; Peter Müller
Journal:  Scand Stat Theory Appl       Date:  2012-03       Impact factor: 1.396

5.  CENTER-ADJUSTED INFERENCE FOR A NONPARAMETRIC BAYESIAN RANDOM EFFECT DISTRIBUTION.

Authors:  Yisheng Li; Peter Müller; Xihong Lin
Journal:  Stat Sin       Date:  2011       Impact factor: 1.261

6.  Bayesian Nonparametric Inference - Why and How.

Authors:  Peter Müller; Riten Mitra
Journal:  Bayesian Anal       Date:  2013       Impact factor: 3.728

7.  Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.

Authors:  Sheng Luo; Xiao Su; Stacia M DeSantis; Xuelin Huang; Min Yi; Kelly K Hunt
Journal:  Stat Med       Date:  2014-01-29       Impact factor: 2.373

Review 8.  Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods.

Authors:  Lucy M Bull; Mark Lunt; Glen P Martin; Kimme Hyrich; Jamie C Sergeant
Journal:  Diagn Progn Res       Date:  2020-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.